Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice
The RESPOND Study and RESPOND Extension Cohort
Nicolas M. Van Mieghem, Jochen Wöhrle, David Hildick-Smith, Sabine Bleiziffer, Daniel J. Blackman, Mohamed Abdel-Wahab, Ulrich Gerckens, Axel Linke, Hüseyin Ince, Peter Wenaweser, Dominic J. Allocco, Ian T. Meredith and Volkmar Falk
1-Year Mortality Across Patient Subgroups in the RESPOND Main Cohort
An analysis was performed across different patient subgroups to identify baseline variables potentially associated with death at 1 year; p value is from the Wald test. CABG = coronary artery bypass graft; COPD = chronic obstructive pulmonary disease; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention; RESPOND = Repositionable Lotus Valve System—Post-Market Evaluation of Real World Clinical Outcomes trial; STS = Society of Thoracic Surgeons.